Cytheris Investors

24 investors on Angel Roster list Cytheris in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the Netherlands, the United States and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name Cytheris can appear together.

Investors listed
24
With verified email
33%
Most common stage
Seed
Top location
Netherlands

Updated October 13, 2026 · How we compile this data

Top 24 Cytheris investors

The most complete profiles first. Showing 24 of 24.

  • Antoine BoulangerVerified

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Anastasia KarpovaVerified

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Derek LimVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Verified email available

  • John MontanaVerified

    Venture Capital, Private Equity Firm, Investment Partner · United Kingdom

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Verified email available

  • Kevin KruseVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Verified email available

  • Mark BenedettiVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Verified email available

  • Mark MackeyVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Verified email available

  • Mathias BurghardtVerified

    Private Equity Firm · France

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Verified email available

  • Geert

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Holger Reithinger

    Venture Capital, Investor · Germany

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Juliette Audet

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Martien van Osch

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more

    Contact details available

  • Rogier Rooswinkel

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Wouter Joustra

    Venture Capital, Investor · Netherlands

    SeedHealth CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Asiya Giniatullina

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Benoit Verbrugghe

    Private Equity Firm · United Kingdom

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Contact details available

  • Bonnie van Wilgenburg

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Carlo Incerti

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Jan Philipp Schmitz

    Private Equity Firm · Germany

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Contact details available

  • Philippe Poletti

    Private Equity Firm · France

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Contact details available

  • Sander van Deventer

    Venture Capital · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vincent Fandozzi

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Contact details available

  • Vincent van Houten

    Venture Capital, Private Equity Firm, Investment Partner · Netherlands

    Health CareGeneticsWellnessLife Science

    Portfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more

    Contact details available

  • Vladimir Colas

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Arkadin, Kudan, Oxxius, Bio7 Group and 86 more

    Contact details available

Frequently asked questions

How many Cytheris investors are on Angel Roster?

Angel Roster lists 24 Cytheris investors. 8 of them (33%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (16), Venture Capital Firms (14) and Investment Partner Investors (6). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Cytheris investors invest in?

Among those that list a stage, the most common are Seed (7).

Where are Cytheris investors based?

Most are based in the Netherlands (12), the United States (6) and Germany (2).

Which companies have Cytheris investors backed?

The most-backed portfolio companies among them are Oxular (14), Catalym (14), Inflazome (14), Xention (14) and Pieris AG (14).

How do I contact Cytheris investors?

Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.